Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of PLX038 in Patients With Advanced Solid Tumors

NCT02646852 is registered in ClinicalTrials.gov with ProLynx LLC as lead sponsor.

NCT NCT02646852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02646852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of PLX038 in Patients With Advanced Solid Tumors
Lead sponsor
ProLynx LLC
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2016
Completion date
July 31, 2023
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, neoplasms, tumors